Jonathan Marc Cohen

This inventor holds 10 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Wyeth, Wyeth Holdings Corporation, Pfizer Corporation. Active years: 2005-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jonathan Marc Cohen. Retrieved from https://idiyas.com/inventor/jonathan-marc-cohen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 4)

% Patents Active = 90.0

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 5.0

ph-index = 6

Forward Citations = 139(Granted Patents)

Location History:

(2016)
Monroe, NY (US) (2005 - 2019)

Company Filing History:

Wyeth Holdings Corporation

Years Active: 2005-2019

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10507206 - Oral formulations and lipophilic salts of methylnaltrexone (2019-12-17),

2. 10376505 - Oral formulations and lipophilic salts of methylnaltrexone (2019-08-13),

3. 10307417 - Oral formulations and lipophilic salts of methylnaltrexone (2019-06-04),

4. 9314461 - Oral formulations and lipophilic salts of methylnaltrexone (2016-04-19),

5. 8956651 - Oral formulations and lipophilic salts of methylnal trexone (2015-02-17),

6. 8524276 - Oral formulations and lipophilic salts of methylnaltrexone (2013-09-03),

7. 8133883 - Compositions containing piperacillin and tazobactam useful for injection (2012-03-13),

8. 7915229 - Compositions containing piperacillin and tazobactam useful for injection (2011-03-29),

9. 7498312 - Compositions containing piperacillin and tazobactam useful for injection (2009-03-03),

10. 6900184 - Compositions containing pipercillin and tazobactam useful for injection (2005-05-31),

Title: Innovation Spotlight: Inventor Jonathan Marc Cohen

Introduction:

Jonathan Marc Cohen, a prolific inventor based in Monroe, NY, has made significant contributions to the field of healthcare through his groundbreaking patents. With an impressive portfolio of 10 patents, Cohen's work focuses on oral formulations and lipophilic salts, particularly methylnaltrexone.

Latest Patents:

Cohen's latest patents revolve around innovative compositions comprising methylnaltrexone or its salts for oral administration. These formulations offer new possibilities for drug delivery and efficacy in the realm of healthcare. The advancements made by Cohen highlight his dedication to improving patient care and treatment options.

Career Highlights:

Throughout his career, Jonathan Marc Cohen has worked with esteemed companies such as Wyeth and Wyeth Holdings Corporation. His time at these organizations allowed him to further develop his innovative ideas and bring them to fruition. Cohen's ingenuity and passion for creating novel solutions have led to the successful implementation of his patented inventions.

Collaborations:

In his professional journey, Cohen has collaborated with talented individuals such as Syed Muzafar Shah and Christopher Richard Diorio. These partnerships have not only fostered a creative environment but have also resulted in the development of groundbreaking technologies that have the potential to revolutionize the healthcare industry.

Conclusion:

In conclusion, Jonathan Marc Cohen stands out as a visionary inventor whose dedication to advancing oral formulations and lipophilic salts has significantly impacted the field of healthcare. His collaborative spirit and commitment to innovation continue to inspire future generations of inventors. Cohen's trailblazing work serves as a testament to the power of creativity and ingenuity in driving meaningful change.

Profile summary based on public USPTO records.